AI assistant
Sending…
LISATA THERAPEUTICS, INC. — Director's Dealing 2011
Dec 19, 2011
34931_dirs_2011-12-19_bd62c0bd-3502-4303-bc29-88fb33f69b0c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: NeoStem, Inc. (NBS)
CIK: 0000320017
Period of Report: 2011-12-15
Reporting Person: Kolbert Jason (See Remarks)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-12-15 | Common Stock, $0.001 par value | P | 2900 | $0.586 | Acquired | 7900 | Direct |
| 2011-12-15 | Common Stock, $0.001 par value | P | 100 | $0.5848 | Acquired | 8000 | Direct |
More from LISATA THERAPEUTICS, INC.
Merger & Acquisition
2026
Jun 1
Regulatory Filings
2026
Jun 1
Merger & Acquisition
2026
May 29
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 11
Regulatory Filings
2026
May 4
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 28
Regulatory Filings
2026
Apr 15
Regulatory Filings
2026
Apr 15